Bingjun Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bingjun Gao has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Boyi Jiang
Department of Osteology, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University , Danyang , Jiangsu, 212300 , China
1 shared publicationXin Cheng
Department of Osteology, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University , Danyang , Jiangsu, 212300 , China
1 shared publicationYarong Wu
Department of Osteology, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University , Danyang , Jiangsu, 212300 , China
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 19 (1) , 20220884
Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
Delayed or failed bone healing is a significant clinical challenge worldwide. Bone marrow mesenchymal stem cells (BMSCs) offer a promising approach for improving fracture healing. Isomangiferin, a xanthone C-glucoside, is known for its pharmacological activities, but its role in fracture healing remains unclear. In this study, we investigated the effects of isomangiferin on BMSCs under oxidative stress conditions induced by hydrogen peroxide (H2O2). Our results showed that isomangiferin promotes osteogenic differentiation and migration of H2O2-treated BMSCs, reduces apoptosis and reactive oxygen species production, and activates the AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK/ACC) pathway. These findings suggest that isomangiferin may be a potential therapeutic agent for enhancing bone healing by modulating BMSC function.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 19 (1) , 20220884
Open AccessIsomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
Delayed or failed bone healing is a significant clinical challenge worldwide. Bone marrow mesenchymal stem cells (BMSCs) offer a promising approach for improving fracture healing. Isomangiferin, a xanthone C-glucoside, is known for its pharmacological activities, but its role in fracture healing remains unclear. In this study, we investigated the effects of isomangiferin on BMSCs under oxidative stress conditions induced by hydrogen peroxide (H2O2). Our results showed that isomangiferin promotes osteogenic differentiation and migration of H2O2-treated BMSCs, reduces apoptosis and reactive oxygen species production, and activates the AMP-activated protein kinase/acetyl-CoA carboxylase (AMPK/ACC) pathway. These findings suggest that isomangiferin may be a potential therapeutic agent for enhancing bone healing by modulating BMSC function.